SCHEMBL30865079

SCHEMBL30865079

CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 9/20 0.58
▸ KISS1R Q969F8 5/20 0.52
▸ BACE2 Q9Y5Z0 3/20 0.51
▸ NPY1R P25929 1/20 0.49
▸ NPY2R P49146 1/20 0.49
▸ NPY4R P50391 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30184408 0.98 BACE1 (0.56) BACE1KISS1RBACE2NPY1RNPY2R
SCHEMBL31690550 0.96 KISS1R (0.56) BACE1KISS1RBACE2
SCHEMBL30184172 0.95 KISS1R (0.53) BACE1KISS1RBACE2NPY1RNPY2R
SCHEMBL29678306 0.93 KISS1R (0.56) BACE1KISS1RBACE2
SCHEMBL31690551 0.93 KISS1R (0.56) BACE1KISS1RBACE2
SCHEMBL30865069 0.93 KISS1R (0.54) BACE1KISS1RNPY1RNPY2RNPY4R
SCHEMBL31696338 0.91 BACE1 (0.67) BACE1KISS1RBACE2
SCHEMBL29627568 0.89 KISS1R (0.54) BACE1KISS1RBACE2
SCHEMBL30752385 0.89 VIPR1 (0.52) BACE1KISS1R
SCHEMBL30752387 0.89 VIPR1 (0.52) BACE1KISS1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240041986-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF TYPE 1 DIABETES DR. MARY MORRIS & ASSOCIATES, LLC (US) 2024-02-08 — — US disclosed
Send feedback